Seroconversion and outcomes after initial and booster COVID-19 vaccination in adults with hematologic malignancies.

Autor: Ollila TA; Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, Rhode Island, USA., Masel RH; Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA., Reagan JL; Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, Rhode Island, USA., Lu S; Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA.; Department of Pathology and Laboratory Medicine, Rhode Island Hospital, Providence, Rhode Island, USA., Rogers RD; Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA.; Division of Infectious Disease, Rhode Island Hospital, Providence, Rhode Island, USA., Paiva KJ; Department of Pathology and Laboratory Medicine, Rhode Island Hospital, Providence, Rhode Island, USA., Taher R; Division of Hematology-Oncology, Rhode Island Hospital, Providence, Rhode Island, USA., Burguera-Couce E; Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA., Zayac AS; Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, Rhode Island, USA., Yakirevich I; Division of Hematology-Oncology, Rhode Island Hospital, Providence, Rhode Island, USA., Niroula R; Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, Rhode Island, USA., Barth P; Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, Rhode Island, USA., Olszewski AJ; Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA.; Division of Hematology-Oncology, Rhode Island Hospital, Providence, Rhode Island, USA.

Publikováno v: Cancer [Cancer] 2022 Sep 15; Vol. 128 (18), pp. 3319-3329. Date of Electronic Publication: 2022 Jul 11.

Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin's Lymphoma: A Single-Center Cohort Study.

Autor: Saito, Makoto¹ (AUTHOR) ikyoku@aiiku-hp.or.jp, Mori, Akio¹ (AUTHOR), Ishio, Takashi¹ (AUTHOR), Kobayashi, Mirei¹ (AUTHOR), Tsukamoto, Shihori¹ (AUTHOR), Kajikawa, Sayaka¹ (AUTHOR), Yokoyama, Emi¹ (AUTHOR), Kanaya, Minoru¹ (AUTHOR), Izumiyama, Koh¹ (AUTHOR), Muraki, Haruna² (AUTHOR), Morioka, Masanobu¹ (AUTHOR), Kondo, Takeshi¹ (AUTHOR)

Publikováno v: Viruses (1999-4915). Mar024, Vol. 16 Issue 3, p328. 16p.

Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic Malignancies.

Autor: Huang, Chien-Tzu^1,2 (AUTHOR) gankay18@hotmail.com, Lee, Ching-Ping¹ (AUTHOR) 890218@kmuh.org.tw, Chen, Tzu-Yin³ (AUTHOR) zuin1228@gmail.com, Liu, Yi-Chang^1,2 (AUTHOR) ycliu@cc.kmu.edu.tw, Cho, Shih-Feng^1,2 (AUTHOR) sifong96@gmail.com, Du, Jeng-Shiun^1,2 (AUTHOR) ashiun@gmail.com, Yu, Ming-Lung^4,5 (AUTHOR) fish6069@gmail.com, Huang, Chung-Feng^4,6 (AUTHOR) fengcheerup@gmail.com, Wang, Sheng-Fan^7,8 (AUTHOR) kmuwasf1234@gmail.com, Hsiao, Hui-Hua^1,2 (AUTHOR) huhuhs@kmu.edu.tw

Publikováno v: Journal of Clinical Medicine. Sep2023, Vol. 12 Issue 17, p5647. 12p.

Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis.

Autor: Liatsou, Efstathia¹ (AUTHOR), Ntanasis-Stathopoulos, Ioannis¹ (AUTHOR), Lykos, Stavros¹ (AUTHOR), Ntanasis-Stathopoulos, Anastasios¹ (AUTHOR), Gavriatopoulou, Maria¹ (AUTHOR), Psaltopoulou, Theodora¹ (AUTHOR), Sergentanis, Theodoros N.² (AUTHOR), Terpos, Evangelos¹ (AUTHOR) eterpos@med.uoa.gr

Publikováno v: Cancers. Apr2023, Vol. 15 Issue 8, p2266. 25p.

Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study.

Autor: Vergori, Alessandra, Matusali, Giulia, Cimini, Eleonora, Bordi, Licia, Borrelli, Paola, Lanini, Simone, Palazzi, Roberta, Paulicelli, Jessica, Mariotti, Davide, Mazzotta, Valentina, Notari, Stefania, Casetti, Rita, Francalancia, Massimo, Rosati, Silvia, D'Abramo, Alessandra, Mija, Cosmina, Mencarini, Paola, Milozzi, Eugenia, Caraffa, Emanuela, Sica, Simona

Publikováno v: Vaccines; Jul2024, Vol. 12 Issue 7, p784, 14p